MDS Virtual Congress 2021 » Parkinson's Disease: Cognitive functions

A prospective study of Parkinson’s disease dementia – defining neuropsychological features

E. Stefanova, LJ. Ziropadja, T. Stojkovic, V. Markovic, I. Stankovic, I. Petrovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)

A prospective study of Parkinson’s disease progression towards dementia – dynamics and defining motor features

T. Stojkovic, LJ. Ziropadja, E. Stefanova, V. Markovic, I. Stankovic, I. Petrovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)

Alterations in brain functional network connectivity in Parkinson’s disease patients with MCI

K. Sreenivasan, X. Zhuang, J. Caldwell, A. Ritter, D. Cordes, Z. Mari, V. Mishra (Las Vegas, USA)

Analysis of effectiveness of Montreal Cognitive Assessment as cognitive evaluation method in low education level patients with Parkinson’s disease in the Brazilian Amazon.

B. Koshimoto, A. Escudeiro, R. Feio, D. Moura, M. Montenegro, A. Silva, B. Lobato (Belém, Brazil)

Association between emotional/cognitive factors and postural control in individuals with Parkinson’s disease and freezing of gait

CN. de Oliveira, ACL. de Lima-Pardini, C. Souza, R. Marquesini, LA. Teixeira, CS. Silva-Batista, DB. Coelho (Sp, Brazil)

ASSOCIATION BETWEEN INSULIN RESISTANCE AND DEVELOPMENT OF DEMENTIA IN PATIENTS WITH PARKINSON´S DISEASE

C. Borrue-Fernandez, E. Ferriz (San Sebastian Reyes, Spain)

Associations between Baseline Cognitive Function and Gait Outcomes after Treadmill Training in Parkinson’s disease

R. Amin, J. Phillips, A. Humbert, B. Cholerton, C. Zabetian, I. Mata, V. Kelly (Seattle, USA)

Baseline cognitive profile is closely associated with long-term motor prognosis in newly diagnosed Parkinson’s disease

SJ. Chung, YJ. Kim, YH. Sohn, PH. Lee (Yongin-Si, Republic of Korea)

Cognitive assessment of Parkinson’s Disease patients in a Northeast Brazilian population: Current Challenges

J. Bonfadini, D. Lima, A. Carneiro, J. Luna, A. Damasceno, P. Braga-Neto (Fortaleza, Brazil)

Cognitive Diagnostics for Parkinson’s Disease: A Novel Digitized Approach Using Non-Motor Symptoms

A. Murrar, M. Abu Snineh, M. Herzallah (Jerusalemp, State of Palestine)

Cognitive Impairment in Parkinson’s disease Patients: a Descriptive Study

R. Nindela, A. Kurniawan, Y. Harun, S. Marisdina, I. Irfannuddin (Palembang, Indonesia)

Cognitive impairment in patients with Alzheimer’s disease and Parkinson’s disease

O. Chyniak (Sumy, Ukraine)

Cognitive reserve in non-demented patients with Parkinson’s disease might protect against amyloid burden effect on cognition

B. Fernández-Rodríguez, R. Rodríguez-Rojas, P. Guida, C. Trompeta, D. Mata-Marín, I. Obeso-Martín, L. Vela, L. García-Cañamaque, JA. Obeso, C. Gasca-Salas (Móstoles, Spain)

Cognitive-driven ADL impairment as a predictor for PDD

I. Liepelt-Scarfone, M. Bode, K. Brockmann, T. Gasser, K. Michaelis, S. Nussbaum, HC. Nuerk, C. Schulte, W. Maetzler, M. Zimmermann, D. Berg, S. Becker (Tübingen, Germany)

Comparisons Between Parkinson’s Disease Patients and At-Risk Individuals: Can Olfactory Deficits and Cognitive Measures Serve as Preclinical Markers?

L. Pimer, J. Fisk, M. Khan, R. Mckelvey, H. Robertson, T. Rolheiser, K. Schoffer, K. Good (Halifax, Canada)

Dissociable contribution of serum NfL and p-tau181 to cognitive impairment and mild cognitive impairment in Parkinson’s disease.

J. Pagonabarraga, R. Pérez-González, H. Bejr-Kasem, A. Horta-Barba, I. Aracil-Bolaños, S. Martinez-Horta, E. Rivas-Asensio, J. Perez-Perez, F. Sampedro, A. Campolongo, C. Izquierdo, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

Effects of dopaminergic medication on reinforcement learning in Parkinson’s disease depend on depressive symptoms

J. Tichelaar, C. Sayali, R. Helmich, R. Cools (Nijmegen, Netherlands)

Effects of levodopa on cognitive functions in Parkinson’s disease

S. Ismailova, S. Prokopenko (Krasnoyarsk, Russian Federation)

Emotional and cognitive information processing in obstacle negotiation in patient with Parkinson’s disease and freezing

S. Mezzarobba, M. Grassi, E. Pelosin, P. Manganotti, P. Bernardis (Genova, Italy)

Emotional processing and response times in Parkinson’s disease

A. Botta, G. Lagravinese, E. Pelosin, G. Bonassi, M. Putzolu, C. Cosentino, C. Ponte, S. Mezzarobba, L. Avanzino (Genova, Italy)

Encoding, consolidation, and retrieval performance in memory tasks of MCI and n-MCI patients with Parkinson’s Disease.

J. Heredia, P. Berrones-Silva, X. Ortiz-Jiménez, I. Estrada-Bellman (Monterrey, Mexico)

Facial emotion recognition and social behavioral problems in de novo parkinson’s disease patients

A. Slomp, S. Vander Zee, J. Boertien, M. Gerritsen, T. van Laar, J. Spikman (Groningen, Netherlands)

Falls in Parkinson’s Disease: The Impact of Cognitive Performance

F. Rolim, A. Gomes, V. Santos, D. Torres, F. Carvalho (Fortaleza, Brazil)

Informant vs. Self-ratings of Activities of Daily Living in Parkinson’s Disease patients

S. Becker, S. Nussbaum, K. Michaelis, K. Brockmann, I. Liepelt-Scarfone (Calgary, Canada)

Initial longitudinal analyses of objectively assessed cognitive functional abilities in a cohort with Parkinson’s disease

S. Holden, A. Fought, K. Olson, N. Lopez-Esquibel, T. Carlisle, L. Medina (Aurora, USA)

Is cognitive performance related to motor performance among people with Parkinson disease?

K. Rawson, L. Tueth, T. Baker, J. Cavanaugh, C. Colon-Semenza, T. Deangelis, D. Fulford, T. Nordahl, C. Thomas, M. Lavalley, M. Saint-Hilaire, J. Zajac, T. Ellis, G. Earhart (St. Louis, USA)

Low dose trihexyphenidyl use causes cognitive dysfunction in Parkinson’s disease patients.

L. Popil, M. Gavriliuc, A. Andrusca, O. Gavriliuc (Chisinau, Republic of Moldova)

Mild cognitive impairment does not predict development of dementia up to 15 years after subthalamic deep brain stimulation in Parkinson’s disease

SF. Fjeldhøj, BLC. Thomsen, PMP. Pedersen, SRJ. Jensen, MK. Karlsborg, AL. Løkkegaard (Copenhagen, Denmark)

Motor skills of walking in Parkinson’s disease: towards a better understanding of the cognitive abilities implicated in F8WT.

V. Cian, M. Zarucchi, C. Siri, A. Giobbia, P. Ortelli, G. Frazzitta, M. Canesi (Gravedona Ed Uniti, Italy)

NMDA Receptor Antibodies and Neuropsychiatric Symptoms in Parkinson’s Disease

L. Gibson, T. Pollak, M. Hart, D. Trivedi, T. Nicholson, M. Zandi, K R. Chaudhuri, D. Aarsland (London, United Kingdom)

Parkinson’s Disease, Cognitive Function and Medication Management: A Problem in Routine Care

P. Tierney, O. Kaczmarek, A. Sethi, B. Bumstead, M. Buhse, E. Kravis, B. Anand, M. Zarif, M. Gudesblatt (Patchogue, USA)

Plasma phosphorylated α-synuclein relates to cognitive impairment in patients with Parkinson’s disease

N-N. Che (Nangjing, China)

Prognostic Modeling of Parkinson’s Disease Progression Using Early Longitudinal Patterns of Change

X. Ren, J. Lin, G. Stebbins, C. Goetz, S. Luo (Foster City, CA, USA)

Reduced Alpha suppression & altered EEG signal complexity in Parkinson’s disease – signatures of cognitive impairment?

S M. Keller, A. Meyer, U. Gschwandtner, S M. Beltrani, K. Toloraia, P. Fuhr (Basel, Switzerland)

RELATION BETWEEN COGNITIVE INHIBITORY CONTROL AND ANTICIPATORY POSTURAL ADJUSTMENT DURING A CONFLICTUAL STEP INITIATION TASK IN PARKINSON’S DISEASE INDIVIDUALS.

SM. Hondo, CN. de Oliveira, LS. de Oliveira, RC. Treza, MJ. Carvalho, AC. de Lima-Pardini, DB. Coelho (Sp, Brazil)

Sex-Specific White Matter Correlates of Neuropsychological Measures in Parkinson’s disease with Mild Cognitive Impairment

V. Mishra, K. Sreenivasan, D. Cordes, A. Ritter, Z. Mari, J. Caldwell (Las Vegas, USA)

Shannon entropy: a novel tool for assessing pentagon drawing in Parkinson’s disease

L. Brabenec, P. Klobusiakova, J. Mekyska, I. Rektorova (Brno, Czech Republic)

Sociodemographic, cognitive, and clinical factors explaining financial-arithmetic errors in Parkinson’s Disease

H. Loenneker, S. Becker, S. Nussbaum, H-C. Nuerk, I. Liepelt-Scarfone (Tuebingen, Germany)

Statistical methods for dealing with missing data in longitudinal studies with application to Parkinson’s disease cognition research

P. Zhang, S. Xie (Philadelphia, USA)

Subjective cognitive complaints assessed with the cognitive domain of the Non-Motor Symptoms Scale predict longitudinal cognitive trajectory in people with Parkinson’s disease with normal cognition

L. Batzu, DJ. van Wamelen, D. Urso, V. Leta, A. Podlewska, K. Rukavina, J. Staunton, YM. Wan, A. Rizos, K. Ray Chaudhuri (London, United Kingdom)

Systematic review of cognitive subtypes derived from data driven approaches in Parkinson’s disease

D. Pourzinal, J. Yang, R. Lawson, K. Mcmahon, G. Byrne, N. Dissanayaka (Herston, Australia)

THE ABILITY OF PATIENTS WITH PARKINSON’S DISEASE TO RECOGNIZE MASKED FACES DURING COVID-19 PANDEMIC

S. Tezcan Aydemir, M. Kuzu Kumcu, N. Durmaz çelik, B. Bakirarar, S. özkan, M. Akbostancı (Ankara, Turkey)

The dual cognitive syndrome in Parkinson’s disease: a resting-state functional connectivity study

Q. Devignes, C. Bordier, R. Viard, G. Carey, L. Defebvre, A. Leentjens, R. Lopes, K. Dujardin (Lille, France)

The Functional Impact of REM Sleep Behavior Disorder in Parkinson’s Disease with Mild Cognitive Impairment

R. Schade, E. Bayram (La Jolla, USA)

The retrograde procedural memory in people with Parkinson’s disease with or without freezing of gait – a cross-sectional study.

L. Pauly, A. Rauschenberger, C. Pauly, M. Hansen, L. Pavelka, A. Hanff, V. Schröder, A. Leist, R. Krüger (Esch-Sur-Alzette, Luxembourg)

The volume of STN tissue activated by DBS and the strength of its structural connectivity with SMA predicts the effects of STN-DBS on response inhibition

G. Meyer, M. Albares, S. Thobois, E. Broussolle, G. Polo, P. Baraduc, B. Ballanger, ML. Welter, B. Lau, P. Boulinguez (Bron, France)

White matter and cognition in Parkinson’s disease

S. Ryman, C. Wertz, K. Poston, N. Shaff, A. Hartman, A. Horner, A. Mayer, A. Vakhtin, A. Deligtisch, S. Pirio Richardson (Albuquerque, USA)